Management of Basal Ganglia Hemorrhage

Initial Assessment and Management

• The American Heart Association recommends performing an immediate non-contrast CT scan to confirm intracerebral hemorrhage and assess hematoma volume, location, and presence of intraventricular extension 1
• The American Stroke Association suggests calculating a baseline severity score (Glasgow Coma Scale or NIHSS) as part of initial evaluation 1
• Patients with basal ganglia hemorrhage should be admitted to an intensive care unit or dedicated stroke unit with physician and nursing neuroscience acute care expertise for initial monitoring and management 1
• Continuous monitoring of blood pressure, neurological status, and vital signs is essential in the management of basal ganglia hemorrhage 2, 3

Blood Pressure Management

• The American College of Cardiology recommends intensive blood pressure lowering to 130-140 mmHg within 1 hour for patients presenting within 6 hours with SBP 150-220 mmHg and no immediate surgery planned 3, 4
• The European Society of Cardiology suggests using small boluses of labetalol for hypertension management, with increased sedation as needed 2, 3
• Avoiding hypotension (systolic <110 mmHg) is crucial as it can worsen secondary cerebral injury and adversely affect neurological outcome 2, 3, 5
• Maintaining SBP >100 mmHg or MAP >80 mmHg is necessary to ensure adequate cerebral perfusion 5

Reversal of Coagulopathy

• The American Heart Association recommends immediate administration of prothrombin complex concentrate (PCC) plus intravenous vitamin K for patients on warfarin with elevated INR 2, 3
• The use of fresh frozen plasma (FFP) for warfarin reversal is not recommended; PCC is superior as it rapidly reverses coagulopathy while limiting fluid volumes 2, 3
• Platelet transfusion is recommended for patients with severe thrombocytopenia 1
• Appropriate factor replacement therapy is necessary for patients with severe coagulation factor deficiency 1

Fluid Management

• The European Society of Intensive Care Medicine recommends using 0.9% normal saline exclusively as the crystalloid of choice to prevent worsening cerebral edema 2, 3, 5
• Hypotonic solutions, including Ringer's lactate, Ringer's acetate, and gelatins, should be avoided as they increase brain water content when real osmolality is measured 2, 3, 5
• Albumin or synthetic colloids should not be used in early management of brain-injured patients 2, 3
• Maintaining euvolemia through cautious use of isotonic fluids while preventing volume overload is essential 2, 3, 5

Management of Hypotension

• Correcting hypovolemia first, then reassessing sedation levels, is crucial in managing hypotension 2, 3
• Administering small bolus of alpha-agonist (metaraminol) followed by infusion, or noradrenaline via central venous catheter only, is recommended 2, 3
• Transferring a hypotensive, actively bleeding patient should be avoided as bleeding control takes precedence over transfer 2, 3

Venous Thromboembolism Prophylaxis

• The American College of Chest Physicians recommends beginning intermittent pneumatic compression on the day of hospital admission for DVT prevention 1
• Graduated compression stockings should be avoided in acute ICH 6

Glucose Management

• The American Diabetes Association recommends monitoring glucose levels closely and avoiding both hyperglycemia and hypoglycemia 1

Seizure Management

• The American Academy of Neurology suggests treating clinical seizures immediately with antiseizure drugs 1
• For patients with altered mental status, performing EEG and treating electrographic seizures with antiseizure drugs is recommended 1
• Prophylactic antiseizure drugs should not be used routinely unless seizures are documented 1

Aspiration Prevention

• The American Speech-Language-Hearing Association recommends performing formal dysphagia screening before initiating any oral intake to reduce pneumonia risk 1

Surgical Considerations for Basal Ganglia Hemorrhage

• The American Heart Association states that the usefulness of surgery for basal ganglia ICH is not well established 7, 1
• Hematoma evacuation should be considered as a life-saving measure only in deteriorating patients 7, 1
• Ultra-early craniotomy (within 4 hours) is associated with increased rebleeding risk and is not recommended 7, 8
• Minimally invasive aspiration techniques show promise but effectiveness remains uncertain 7, 1
• Decompressive craniectomy with or without hematoma evacuation might reduce mortality for comatose patients with large hematomas, significant midline shift, or elevated ICP refractory to medical management 7, 1

Management of Intraventricular Extension

• The American Heart Association recommends considering external ventricular drainage for hydrocephalus if intraventricular hemorrhage is present 9
• Intraventricular thrombolysis remains investigational and should only be used in clinical trials 9

Critical Pitfalls to Avoid

• Delaying blood pressure lowering beyond 6 hours of symptom onset should be avoided as the therapeutic window is narrow 3, 4
• Using FFP for warfarin reversal should be avoided; PCC should be used to limit fluid volumes 2, 3
• Hypotonic crystalloids like Ringer's lactate should not be used; only 0.9% saline should be used 2, 3, 5
• Instituting DNR orders or withdrawing support in the first 48 hours should be avoided as early prognostication is unreliable and creates self-fulfilling prophecies 10, 9
• Ultra-early surgery (within 4 hours) should not be performed due to increased rebleeding risk 7, 8

Prognostication Caution

• DNR orders should be postponed until at least the second full day of hospitalization unless pre-existing advance directives exist 10, 9
• Aggressive guideline-concordant therapy should be provided for all patients without advance directives specifying otherwise 10, 9
• Current prognostication methods are biased by failure to account for withdrawal of support and early DNR orders 10, 9

Acute Evidence‑Based Management of Basal Ganglia Intracerebral Hemorrhage

Intracranial Pressure (ICP) Management

• Elevating the head of the bed to 20–30° improves venous drainage and helps control ICP in patients with acute basal ganglia hemorrhage. American Heart Association/American Stroke Association recommendation. 11
• Initial ICP control should begin with simple measures—analgesia, adequate sedation, and head‑of‑bed elevation—before escalating therapy. AHA/ASA. 11
• When ICP is elevated, osmotic agents (mannitol or hypertonic saline), CSF drainage via a ventricular catheter, neuromuscular blockade, and controlled hyperventilation are employed to keep cerebral perfusion pressure > 70 mmHg. AHA/ASA. 11
• Aggressive ICP‑lowering interventions must be accompanied by continuous ICP and arterial blood‑pressure monitoring to avoid secondary injury. AHA/ASA. 11

Glucose and Seizure Management

• Hyperglycemia (>140 mg/dL) should be monitored and treated; insulin therapy is indicated when glucose exceeds 185 mg/dL. AHA/ASA. 11
• Routine prophylactic antiseizure medication is not recommended for basal ganglia hemorrhage, but a short course may be considered in lobar hemorrhages. AHA/ASA. 11

Deep‑Vein Thrombosis (DVT) Prophylaxis

• After hemorrhage stabilization (typically 48–72 h), low‑molecular‑weight heparin or unfractionated heparin can be initiated for DVT prevention, although supporting evidence is limited. AHA/ASA. 11

Surgical Decision‑Making

Evidence from Randomized Trials

• The STICH trial showed that minimally invasive surgery for deep basal ganglia hemorrhages resulted in an odds ratio of 1.3 for poor functional outcome compared with best medical therapy, indicating no clear benefit of surgery. AHA/ASA. [12][13]

Decompressive Craniectomy

• In comatose patients with large basal ganglia hematomas, significant midline shift, or refractory ICP, decompressive craniectomy (with or without hematoma evacuation) may lower mortality. AHA/ASA. 13

Minimally Invasive Techniques

• Endoscopic evacuation or stereotactic aspiration with thrombolytic adjuncts are promising but remain investigational for deep hemorrhages. AHA/ASA. [12][13]

Ventricular Drainage Without Evacuation

• Using an external ventricular drain alone to control ICP, without concurrent hematoma evacuation, has been associated with potential harm and is not recommended. AHA/ASA. 13